Lipoprotein (a), LPA Ile4399Met, and fibrin clot properties

Thrombosis Research

Volumn 133, Issue 5, 2014, Pages 863-867

  Rowland, Charles M ^a   Pullinger, Clive R ^b   Luke, May M ^a   Shiffman, Dov ^a   Green, Lauri ^b   Movsesyan, Irina ^b   Devlin, James J ^a   Malloy, Mary J ^b   Kane, John P ^b   Undas, Anetta ^c  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

fibrin clot; genetics; Lipoprotein(a); polymorphism; thrombosis

Indexed keywords

FIBRIN; FIBRINOGEN; LIPOPROTEIN A;

ADOLESCENT; ADULT; AGED; BLOOD; BLOOD CLOTTING; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; FEMALE; FIBRIN; FIBRINOGEN; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84898790907     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.01.024     Document Type: Article

References (39)

1. J. Danesh, R. Collins, and R. Peto Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies Circulation 102 2000 1082 1085
2. S. Erqou, S. Kaptoge, P.L. Perry, E. Di Angelantonio, A. Thompson, and I.R. White et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
3. R.C. Hoogeveen, J.K. Gambhir, D.S. Gambhir, K.T. Kimball, K. Ghazzaly, and J.W. Gaubatz et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts J Lipid Res 42 2001 631 638
4. B. Boden-Albala, D.E. Kargman, I.F. Lin, M.C. Paik, R.L. Sacco, and L. Berglund Increased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan Stroke Study Cerebrovasc Dis 30 2010 237 243
5. A. Rosengren, L. Wilhelmsen, E. Eriksson, B. Risberg, and H. Wedel Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men BMJ 301 1990 1248 1251
6. S. Tsimikas, E.S. Brilakis, E.R. Miller, J.P. McConnell, R.J. Lennon, and K.S. Kornman et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease N Engl J Med 353 2005 46 57
7. C. Bergmark, A. Dewan, A. Orsoni, E. Merki, E.R. Miller, and M.J. Shin et al. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma J Lipid Res 49 2008 2230 2239
8. N.M. Caplice, C. Panetta, T.E. Peterson, L.S. Kleppe, C.S. Mueske, and G.M. Kostner et al. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis Blood 98 2001 2980 2987
9. E.J. Rodger, R.J. Suetani, G.T. Jones, T. Kleffmann, A. Carne, and M. Legge et al. Proteomic analysis of aortae from human lipoprotein(a) transgenic mice shows an early metabolic response independent of atherosclerosis PLoS One 7 2012 e30383
10. N.A. Goldenberg, T.J. Bernard, J. Hillhouse, J. Armstrong-Wells, J. Galinkin, and R. Knapp-Clevenger et al. Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children Haematologica 98 2013 802 807
11. J.W. McLean, J.E. Tomlinson, W.J. Kuang, D.L. Eaton, E.Y. Chen, and G.M. Fless et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen Nature 330 1987 132 137
12. M.L. Koschinsky, U. Beisiegel, D. Henne-Bruns, D.L. Eaton, and R.M. Lawn Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA Biochemistry 29 1990 640 644
13. C. Lackner, E. Boerwinkle, C.C. Leffert, T. Rahmig, and H.H. Hobbs Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis J Clin Invest 87 1991 2153 2161
14. C. Sandholzer, D.M. Hallman, N. Saha, G. Sigurdsson, C. Lackner, and A. Csaszar et al. Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups Hum Genet 86 1991 607 614
15. E. Angles-Cano, Diaz A. de la Pena, and S. Loyau Inhibition of fibrinolysis by lipoprotein(a) Ann N Y Acad Sci 936 2001 261 275
16. A. Undas, E. Stepien, W. Tracz, and A. Szczeklik Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis J Thromb Haemost 4 2006 973 975
17. A. Undas, K. Szuldrzynski, E. Stepien, J. Zalewski, J. Godlewski, and W. Tracz et al. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress Atherosclerosis 196 2008 551 557
18. A. Undas, P. Podolec, K. Zawilska, M. Pieculewicz, I. Jedlinski, and E. Stepien et al. Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke Stroke 40 2009 1499 1501
19. J.P. Collet, Y. Allali, C. Lesty, M.L. Tanguy, J. Silvain, and A. Ankri et al. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis Arterioscler Thromb Vasc Biol 26 2006 2567 2573
20. K. Fatah, A. Hamsten, B. Blomback, and M. Blomback Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis Thromb Haemost 68 1992 130 135
21. A. Undas, K. Zawilska, M. Ciesla-Dul, A. Lehmann-Kopydlowska, A. Skubiszak, and K. Ciepluch et al. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives Blood 114 2009 4272 4278
22. T. Lisman, P.G. de Groot, J.C. Meijers, and F.R. Rosendaal Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis Blood 105 2005 1102 1105
23. M.M. Luke, J.P. Kane, D.M. Liu, C.M. Rowland, D. Shiffman, and J. Cassano et al. A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease Arterioscler Thromb Vasc Biol 27 2007 2030 2036
24. D. Shiffman, E.S. O'Meara, L.A. Bare, C.M. Rowland, J.Z. Louie, and A.R. Arellano et al. Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study Arterioscler Thromb Vasc Biol 28 2008 173 179
25. D.I. Chasman, D. Shiffman, R.Y. Zee, J.Z. Louie, M.M. Luke, and C.M. Rowland et al. Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy Atherosclerosis 203 2009 371 376
26. R. Clarke, J.F. Peden, J.C. Hopewell, T. Kyriakou, A. Goel, and S.C. Heath et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease N Engl J Med 361 2009 2518 2528
27. J.C. Hopewell, R. Clarke, S. Parish, J. Armitage, M. Lathrop, and J. Hager et al. Lipoprotein(a) Genetic Variants Associated With Coronary and Peripheral Vascular Disease but Not With Stroke Risk in the Heart Protection Study Circ Cardiovasc Genet 4 2011 68 73
28. Y. Li, M.M. Luke, D. Shiffman, and J.J. Devlin Genetic variants in the apolipoprotein(a) gene and coronary heart disease Circ Cardiovasc Genet 4 2011 565 573
29. D.J. Nazir, and M.J. McQueen Monthly intra-individual variation in lipoprotein(a) in 22 normal subjects over 12 months Clin Biochem 30 1997 163 170
30. J.A. Hutcheon, A. Chiolero, and J.A. Hanley Random measurement error and regression dilution bias BMJ 340 2010 c2289
31. C. Ober, A.S. Nord, E.E. Thompson, L. Pan, Z. Tan, and D. Cusanovich et al. Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q J Lipid Res 50 2009 798 806
32. L. Dumitrescu, K. Glenn, K. Brown-Gentry, C. Shephard, M. Wong, and M.J. Rieder et al. Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination Survey PLoS One 6 2011 e16604
33. M.B. Lanktree, S.S. Anand, S. Yusuf, R.A. Hegele, and S. Investigators Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians Circ Cardiovasc Genet 3 2010 39 46
34. D. Shiffman, J.Z. Louie, C.M. Rowland, M.J. Malloy, J.P. Kane, and J.J. Devlin Single variants can explain the association between coronary heart disease and haplotypes in the apolipoprotein(a) locus Atherosclerosis 212 2010 193 196
35. S.T. Lord Molecular mechanisms affecting fibrin structure and stability Arterioscler Thromb Vasc Biol 31 2011 494 499
36. P. Allan, S. Uitte de Willige, R.H. Abou-Saleh, S.D. Connell, and R.A. Ariens Evidence that fibrinogen gamma' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness J Thromb Haemost 10 2012 1072 1080
37. A. Undas, and R.A. Ariens Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases Arterioscler Thromb Vasc Biol 31 2011 e88 e99
38. A. Undas Acquired dysfibrinogenemia in atherosclerotic vascular disease Pol Arch Med Wewn 121 2011 310 319
39. A. Undas, K.E. Brummel-Ziedins, and K.G. Mann Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions Blood 109 2007 2285 2292